BLU-554 (BLU554)
99%
- Product Code: 57622
CAS:
1707289-21-1
| Molecular Weight: | 503.38 g./mol | Molecular Formula: | C₂₄H₂₄Cl₂N₄O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30496704 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
BLU-554 is primarily used in the field of oncology, specifically targeting hepatocellular carcinoma (HCC), which is the most common type of liver cancer. It functions as a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), a receptor often implicated in the progression of HCC. By inhibiting FGFR4, BLU-554 aims to disrupt the signaling pathways that promote tumor growth and survival, offering a potential therapeutic strategy for patients with this aggressive form of cancer. Its development represents a targeted approach to treatment, particularly for patients whose tumors exhibit FGFR4 pathway activation, providing a more personalized and effective treatment option compared to traditional chemotherapy. Clinical trials have been conducted to evaluate its efficacy and safety, with a focus on its ability to shrink tumors and improve patient outcomes in advanced HCC cases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿3,411.00 |
+
-
|
BLU-554 (BLU554)
BLU-554 is primarily used in the field of oncology, specifically targeting hepatocellular carcinoma (HCC), which is the most common type of liver cancer. It functions as a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), a receptor often implicated in the progression of HCC. By inhibiting FGFR4, BLU-554 aims to disrupt the signaling pathways that promote tumor growth and survival, offering a potential therapeutic strategy for patients with this aggressive form of cancer. Its development represents a targeted approach to treatment, particularly for patients whose tumors exhibit FGFR4 pathway activation, providing a more personalized and effective treatment option compared to traditional chemotherapy. Clinical trials have been conducted to evaluate its efficacy and safety, with a focus on its ability to shrink tumors and improve patient outcomes in advanced HCC cases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :